Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide and Dexamethasone for Acute Phase of Perilesional Edema in Calcified Neurocysticercosis
NCT02945527Phase 3Terminated
- Sponsor
- Universidad Peruana Cayetano Heredia
- Start
- Dec 2015
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetazolamide and dexamethasone in neurocysticercosis (NCC) (3 arms), sponsored by Universidad Peruana Cayetano Heredia. Primary endpoint: Decrease in Volume of Perilesional Edema Between Baseline and Day 4. Started Dec 2015; status: terminated.
02
Drugs
acetazolamidedexamethasone
03
Conditions
neurocysticercosis (NCC)
Beyond the preview
Go deeper on NCT02945527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02945527.